Hans Jeppsson
Finanzdirektor/CFO bei VICORE PHARMA HOLDING AB
Vermögen: 8 227 $ am 30.04.2024
Aktive Positionen von Hans Jeppsson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VICORE PHARMA HOLDING AB | Finanzdirektor/CFO | 01.01.2017 | - |
| Public Communications Contact | 01.01.2017 | - | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - | - |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Hans Jeppsson
Ehemalige bekannte Positionen von Hans Jeppsson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Danske Bank A/S (Sweden) | Analyst-Equity | - | - |
Ausbildung von Hans Jeppsson
| University of Gothenburg | Doctorate Degree |
| Handelshögskolan i Göteborg | Doctorate Degree |
Statistik
International
| Schweden | 7 |
Operativ
| Doctorate Degree | 2 |
| Graduate Degree | 2 |
| Analyst-Equity | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VICORE PHARMA HOLDING AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Danske Bank A/S (Sweden) | Finance |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
- Börse
- Insiders
- Hans Jeppsson
- Erfahrung
